Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
SSKN

SSKN - Strata Skin Sciences Inc Stock Price, Fair Value and News

$1.27+0.04 (+3.25%)
Market Closed

29/100

SSKN

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

29/100

SSKN

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$1.02

Target 3M

$1.2

Target 6M

$1.13

SSKN Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

SSKN Price Action

Last 7 days

-0.8%

Last 30 days

-7.3%

Last 90 days

-30.6%

Trailing 12 Months

-55.3%

SSKN RSI Chart

SSKN Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

SSKN Valuation

Market Cap

7.5M

Price/Earnings (Trailing)

-0.69

Price/Sales (Trailing)

0.24

EV/EBITDA

-3.66

Price/Free Cashflow

-2.13

SSKN Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$1.02

Target 3M

$1.2

Target 6M

$1.13

SSKN Fundamentals

SSKN Revenue

Revenue (TTM)

31.0M

Rev. Growth (Yr)

-21.23%

Rev. Growth (Qtr)

-9.58%

SSKN Earnings

Earnings (TTM)

-10.9M

Earnings Growth (Yr)

21.79%

Earnings Growth (Qtr)

37.01%

SSKN Profitability

Operating Margin

57.51%

EBT Margin

-33.11%

Return on Equity

-827.55%

Return on Assets

-35.4%

Free Cashflow Yield

-46.96%

SSKN Investor Care

Shares Dilution (1Y)

41.16%

Diluted EPS (TTM)

-3.07

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202533.6M32.8M31.0M0
202432.5M32.7M32.7M33.6M
202336.7M35.8M35.3M33.4M
202231.2M32.9M34.6M36.2M
202122.2M25.5M27.6M30.0M
202030.8M27.1M25.3M23.1M
201930.6M30.9M30.7M31.6M
201831.2M30.2M30.4M29.9M
201730.4M31.1M30.8M31.8M
201626.0M33.2M32.6M30.7M
2015898.2K1.3M9.4M18.5M
2014489.5K570.1K680.4K914.8K
2013410.9K479.5K518.1K536.0K
2012000278.0K
20100000
Get all data in R, Python etc through our Historical Stock Data APIs

About Strata Skin Sciences Inc

SSKN
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also provides TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
 CEO
 WEBSITEstrataskinsciences.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES114

Strata Skin Sciences Inc Frequently Asked Questions

SSKN is the stock ticker symbol of Strata Skin Sciences Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Strata Skin Sciences Inc is 7.48 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check SSKN's fair value in chart for subscribers.

The fair value guage provides a quick view whether SSKN is over valued or under valued. Whether Strata Skin Sciences Inc is cheap or expensive depends on the assumptions which impact Strata Skin Sciences Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SSKN.

As of Wed Jan 28 2026, SSKN's PE ratio (Price to Earnings) is -0.69 and Price to Sales (PS) ratio is 0.24. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SSKN PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Strata Skin Sciences Inc has provided -0.132 (multiply by 100 for percentage) rate of return.